These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30656000)

  • 1. Impact of hyperprolactinemia in a patient with polyautoimmunity.
    Rojas M; Rodríguez Y; Ramírez-Santana C; Anaya JM
    Clin Case Rep; 2019 Jan; 7(1):19-23. PubMed ID: 30656000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prolactin in connective tissue diseases].
    Parada-Turska J; Targońska-Stepniak B; Majdan M
    Postepy Hig Med Dosw (Online); 2006; 60():278-85. PubMed ID: 16715039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple autoimmune disease in a patient with hyperprolactinemia.
    Anaya JM; Shoenfeld Y
    Isr Med Assoc J; 2005 Nov; 7(11):740-1. PubMed ID: 16309001
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of raised levels of IL-4 and anti-TPO with hyperprolactinemia.
    Kalsi AK; Halder A; Jain M; Chaturvedi PK; Mathew M; Sharma JB
    Am J Reprod Immunol; 2019 Mar; 81(3):e13085. PubMed ID: 30614113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist.
    Rojas-Villarraga A; Amaya-Amaya J; Rodriguez-Rodriguez A; Mantilla RD; Anaya JM
    Autoimmune Dis; 2012; 2012():254319. PubMed ID: 22454759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyautoimmunity in Sjögren Syndrome.
    Anaya JM; Rojas-Villarraga A; Mantilla RD; Arcos-Burgos M; Sarmiento-Monroy JC
    Rheum Dis Clin North Am; 2016 Aug; 42(3):457-72. PubMed ID: 27431348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia and autoimmune diseases.
    Orbach H; Shoenfeld Y
    Autoimmun Rev; 2007 Sep; 6(8):537-42. PubMed ID: 17854745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Polyautoimmunity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    Ordoñez-Cañizares MC; Mena-Vázquez N; Redondo-Rodriguez R; Manrique-Arija S; Jimenez-Núñez FG; Ureña-Garnica I; Fernández-Nebro A
    J Clin Rheumatol; 2022 Jan; 28(1):e38-e43. PubMed ID: 32956154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.
    Orbach H; Zandman-Goddard G; Boaz M; Agmon-Levin N; Amital H; Szekanecz Z; Szucs G; Rovensky J; Kiss E; Doria A; Ghirardello A; Gomez-Arbesu J; Stojanovich L; Ingegnoli F; Meroni PL; Rozman B; Blank M; Shoenfeld Y
    Clin Rev Allergy Immunol; 2012 Apr; 42(2):189-98. PubMed ID: 21287295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing polyautoimmunity in systemic lupus erythematosus.
    Rojas-Villarraga A; Toro CE; Espinosa G; Rodríguez-Velosa Y; Duarte-Rey C; Mantilla RD; Iglesias-Gamarra A; Cervera R; Anaya JM
    Autoimmun Rev; 2010 Feb; 9(4):229-32. PubMed ID: 19819350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation?
    El Miedany YM; Ahmed I; Moustafa H; El Baddini M
    Joint Bone Spine; 2004 May; 71(3):203-8. PubMed ID: 15182791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity.
    Wan Asyraf WA; Mohd Shahrir MS; Asrul W; Norasyikin AW; Hanita O; Kong WY; Azmi MT
    Reumatismo; 2018 Dec; 70(4):241-250. PubMed ID: 30570242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome and systemic lupus erythematosus: links and risks.
    Pasoto SG; Adriano de Oliveira Martins V; Bonfa E
    Open Access Rheumatol; 2019; 11():33-45. PubMed ID: 30774485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactin as an immunomodulatory factor in psoriatic arthritis].
    Kokot I; Pawlik-Sobecka L; Płaczkowska S; Piwowar A
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1265-72. PubMed ID: 24379267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperprolactinemia in systemic lupus erythematosus. A prospective study of 38 cases].
    Smiti Khanfir M; Ben Ghorbel I; Feki M; Lamloum M; Mebazaa A; Miled M; Houman MH
    Tunis Med; 2004 Jun; 82(6):512-5. PubMed ID: 15517949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sjögren's syndrome at the crossroad of polyautoimmunity.
    Amador-Patarroyo MJ; Arbelaez JG; Mantilla RD; Rodriguez-Rodriguez A; Cárdenas-Roldán J; Pineda-Tamayo R; Guarin MR; Kleine LL; Rojas-Villarraga A; Anaya JM
    J Autoimmun; 2012 Sep; 39(3):199-205. PubMed ID: 22749530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin has a pathogenic role in systemic lupus erythematosus.
    Jara LJ; Medina G; Saavedra MA; Vera-Lastra O; Torres-Aguilar H; Navarro C; Vazquez Del Mercado M; Espinoza LR
    Immunol Res; 2017 Apr; 65(2):512-523. PubMed ID: 28130617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis.
    Horimoto AM; Silveira AF; da Costa IP
    Rev Bras Reumatol Engl Ed; 2016; 56(4):314-22. PubMed ID: 27476624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and autoimmunity: The hormone as an inflammatory cytokine.
    Borba VV; Zandman-Goddard G; Shoenfeld Y
    Best Pract Res Clin Endocrinol Metab; 2019 Dec; 33(6):101324. PubMed ID: 31564625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
    Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
    Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.